ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
18 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: Ovarian Cancer Research Fund Woman to Woman Program Grant
A Woman to Woman program grant recipient will receive a one-year grant of no more than $50,000. This grant opportunity is available to any medical institutions with a sufficient volume of gynecologic cancer patients and a need to provide this type of support service to patients. Grants are provided to cover the cost of a part-time Program Coordinator’s salary (can be a new hire, or a reassignment), program costs, and the patient fund (no indirect costs are allowed). It is expected that each Woman to Woman program will become self-funding after the first year.
OCRF will provide all program materials for patients, as well as technical assistance and support, for the life of the program (even after the end of the grant period). Programs will also have access to a dedicated section of the fund's website available to participants only, which will feature tools to assist in the development and administration of new programs.
OCRF is now accepting applications for a Woman to Woman program grant. The deadline for submission is May 1, 2014.
For questions about Woman to Woman, please email Julia Volpin at email@example.com.
Request for Proposals: Brandon C. Gromada Head & Neck Cancer Foundation Research Awards
The Brandon C. Gromada Head & Neck Cancer Foundation is pleased to announce its first annual Research Awards to support investigators in the fight against head and neck cancers.
Researchers interested in submitting a proposal may obtain the Request for Proposals (RFP) document via the web site's Contact page or by sending an email request to firstname.lastname@example.org. The deadline for RFP submission is 5 p.m., March 28, 2014.
Call for Applications: Livestrong Foundation Big C Competition
We're looking for big thinkers to create tangible innovations and solutions improving the daily lives of people facing cancer.
The Big C competition is an opportunity to change the way the world fights cancer.
How it Work
May 15 deadline for submitting your product, service or innovation.
150 semi-finalists have access to mentoring, crowdfunding and media exposure.
Five teams pitch in Austin for a chance to win $25,000!
(60 teams win a total of $140,000)
Solutions We Seek
The Big C competition invites you to submit projects addressing the following needs.
Rebuild Financial Health
Regain Emotional Wellbeing
Care for Caregivers
Improve Access to Quality Care
Fill the Knowledge Gap
Help Anyone Facing Cancer Now
Call for Applications: Alex's Lemonade Stand Foundation Reach Awards
Alex's Lemonade Stand Foundation (ALSF) evolved from the front yard lemonade stand of cancer patient Alexandra “Alex” Scott (1996-2004) into a national fundraising movement to raise awareness and find cures for all childhood cancers.
Reach Awards are designed to move hypothesis-driven research toward the clinic. A successful application will identify an unmet clinical need relevant to the care of patients with pediatric cancer and describe how the work performed will allow for the translation of hypothesis-driven research to the clinic keeping broader clinical testing and implementation in view.
All Reach Award applications must be received by May 30, 2014 - 11:59 PM ET.
Maximum of $250,000 in total costs awarded over two years.
All applications must be submitted using ALSF’s online submission process.
The purpose of the Reach Award is to advance ALSF’s mission to find cures and better treatments for childhood cancers by providing support to move hypothesis-driven research into the clinic. Significant barriers exist that impede the translation of innovative and important ideas to the clinic. The Reach Award seeks to remove one of these barriers by providing support for important pre-clinical projects that are necessary to move a study from the pre-clinical arena into a clinical trial. Thus, the goal of this award is to support selected “late translational” studies needed to ultimately initiate a clinical trial. Preference will be given to those research projects which, if funded, will result in the initiation of a clinical trial within two to three years.
Primary applicants may be Assistant, Associate or Professor level investigators who demonstrate a track record of discovery, investigation and external funding. Applicants may be M.D., D.O., Ph.D, or M.D./Ph.D. Applicants must have a demonstrated track record of pediatric cancer research with experience in translational research Multiple investigator applications that bring together pairs or teams of researchers with complementary expertise are encouraged. Phase I/II Trials are not eligible for funding by this grant mechanism.
Call for Applications: Alex's Lemonade Stand Foundation ‘A’ Awards
The ‘A’ Award is a three-year grant designed for the early career scientist who wants to establish their career in pediatric oncology research. The ideal applicant has an original project that is not currently being funded. Demonstration of outstanding mentorship and a future commitment to pediatric cancer investigation are critical components of a successful application. Institutional commitment to the career of the applicant is also expected.
All applications must be received by May 23, 2014 - 11:59 PM ET.
This award totals $450,000 over three years and is open to MD, MD/PhD and PhD candidates.
‘A’ Award Program Goals To encourage the best and brightest early career researchers to build lifelong careers and become leaders in the field of pediatric cancer research. To advance research that will lead to new treatments and cures impacting children with cancer.
Highlights NEW in 2014: ALSF increased the award to $450,000 over 3 years ($150,000 per year) Recipient will have the opportunity to speak at and attend Foundation events In addition to the grant funds, the "A‟ Award provides
-- reference books to enhance personal pediatric oncology library
-- equipment to enhance lab/project work up to $10,000
-- registration fees for one educational course or event
Eligibility Criteria (Updated for 2014!) Proposals must be aligned with ALSF's mission and "A‟ Award program goals. Applicants must have an M.D., Ph.D. or dual M.D., Ph.D. (D.O., MBBS or equivalent) and must not have achieved an appointment higher than assistant professor. In addition,
-- M.D. and M.D., Ph.D. Applicants
o M.D. or M.D., Ph.D. applicants must be no more than 6 years after finishing 3-year fellowship at the time the award would start (i.e. fellowship ended in 2008 or later) and be no more than 12 years since receiving the most recent professional degree (Ph.D, M.D., D.O., MBBS or equivalent) at the time the award would start. Preference will be given to applicants no more than 12 years since receiving the first professional degree.
o M.D. candidates who did not have a 3-year fellowship must have 3 years of research experience after M.D. was awarded and be no more than 12 years since receiving the M.D. at the time the award would start.
-- Ph.D. Applicants
o Ph.D. applicants must be no more than 6 years since being awarded Ph.D. (i.e., if Ph.D. is awarded in 2008 or later, applicant is eligible for 2014 "A‟ Award). A minimum of 75% of the applicant's time during "A‟ Award must be allocated as protected time for all research activities. Applicants holding K99/R00, R01 are not eligible.
Applicants MAY have research grants from other funding sources during the "A‟ Award period, but there must be clear documentation of mechanisms to avoid scientific and budgetary overlap. Current ALSF Grant Recipients
-- Applicants currently holding an ALSF 2012 Young Investigator Award, ending June 30, 2014, are eligible to apply.
-- Applicants currently holding an ALSF 2013 Young Investigator Award or are Center of Excellence Scholars are not eligible.
-- Applicants currently holding ALSF's Innovation, Reach, Phase I/II Infrastructure or Epidemiology grants are not eligible to apply for the 2014 "A‟ Award. Prior Young Investigator applicants: If you are submitting a Young Investigator application previously reviewed but not funded by ALSF for the "A‟ Award, you must complete the resubmission section: respond to critiques, describe changes and/or new data etc. A detailed mentoring plan for career development must be clearly articulated with appropriate letters of support. Institutional commitment to the applicant's career must be addressed. Funds must be granted to nonprofit institutions or organizations operating in the United States or Canada. Researchers need not be U.S. citizens.
Resubmissions: Only one resubmission of a previously reviewed "A‟ Award or Young Investigator proposal is permitted.
Call for Applications: Alex's Lemonade Stand Foundation Springboard Grants
Springboard Grants are in response to cut-backs in National Institutes of Health (NIH) funding of new R01 and P01 applications. The Springboard Grant is designed to jump-start new projects with high impact potential for childhood cancer research while other funding is sought.
All applications must be received by April 10, 2014 - 11:59 PM ET.
This is a one year award of $100,000 in total costs.
All applications must be submitted via ALSFgrants.org.
ALSF’s Springboard Grant is designed to support new National Institutes of Health (NIH)* R01 or P01 research projects which were scored less than or equal to the 20th percentile but were not funded. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Springboard Grant.
Eligibility: Researchers must have applied to the NIH for an R01 or P01 award and received notification dated within the last 6 months. (R01 Supplements are not eligible for Springboard Grants) Applications must have scored ≤25% but outside of the agency’s fundable range. If submitting a project from a NIH P01 application, the project must have scored at 3.0 or better in the initial review.
o If resubmitting the project to the NIH as a R01, only include the NIH project review.
o If resubmitting the project to the NIH in a P01, you must include the entire P01 review from the NIH. Applicants must be reapplying for an R01 or P01 award from the NIH within the next two NIH Grant cycles. The original NIH application must be aligned with ALSF’s mission, and thus must be directly relevant to pediatric cancer. Funds may be used for supplies, personnel, or PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs.
Call for Applications: Alex's Lemonade Stand Foundation Bridge Grants
This is a one year award of $100,000 in total costs
ALSF’s Bridge Grant is designed to sustain research projects falling between the end of funding by the National Institutes of Health (NIH) R or P Award and the beginning of a competitively renewed NIH Award. ALSF will support projects via this mechanism for a maximum of 12 months. If NIH funding is secured and begins before the end of this 12 month period, ALSF must be notified and will cease its financial support of the project. Projects funded via this mechanism that do not receive funding from the NIH within 12 months are not eligible to reapply for the ALSF Bridge Grant.
Eligibility: Project must have been previously funded by NIH R01, R03, R21 or P01 Award. (R01 Supplements are not eligible for Bridge Grants) Researchers must have applied to the NIH for an R01 or P01 renewal for an ongoing project or to continue the project via new R01 or P01 and received notification dated within the last 6 months. The R01 application must have scored ≤35th percentile but outside of the agency’s fundable range. If submitting a project from a NIH P01 application, the project must have scored at 3.0 or better in the initial review.
o If resubmitting the project to the NIH as a R01, only include the NIH project review
o If resubmitting the project to the NIH in a P01, you must include the entire P01 review from the NIH Applicants must be reapplying for an R01 or P01 Award from the NIH within the next two NIH Grant cycles. The original NIH project must be aligned with ALSF’s mission, and thus must be directly relevant to pediatric cancer. Funds may be used for supplies, personnel, and PI’s salary and may not exceed $100,000. ALSF does not pay indirect costs.
Call for Applications: American Gastroenterological Association-Aptalis Research Award in Pancreatic Disease
Eligibility: Young Investigators
Duration: Two years
Deadline: June 6, 2014
Start Date: Oct. 1, 2014
This award provides $50,000 per year for two years (total $100,000) to young investigators, instructors, research associates or equivalents interested in the function and disorders of the exocrine pancreas. Research topics suitable for funding under this grant include but are not limited to: pancreatitis, pancreatic cancer, pancreatic insufficiency, the gut microbiome-pancreas relationship, pancreatic disease epidemiology or genetics (excluding diabetes), and pancreatic disease biomarkers.
The overall objective of this career development award is to encourage and support research into exocrine pancreatic disorders by helping to sustain the careers of young investigators with an interest in pancreatic disease.
• Candidates for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by June 1, 2014.
• AGA membership is required at the time of application submission. Please visit the membership page or call 301-654-2055, extension 651, for membership information.
• The award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Candidates should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates.
• MD applicants: no more than seven years shall have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
• PhD applicants: no more than seven years shall have elapsed following the awarding of a PhD and the start date of this award.
• Women and underrepresented minority applicants are strongly encouraged to apply; these applications in particular will receive the review committee’s full consideration.
• An appropriately documented parental leave of absence will not be counted toward the above noted seven-year eligibility criteria. Exceptional circumstances may also be considered.
• All submissions must be relevant to diagnosing, treating or researching the functions or diseases of the exocrine pancreas.
• At the time of application submission, candidates may not hold or have held an NIH R01, R29, R21, K08, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (such as the American Liver Foundation, Burroughs Wellcome Fund, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation, etc.). Candidates with an active K12 may apply.
• The intent of this award is to foster the scientific independence of junior investigators. It is understood that there may be some overlap with work funded by the mentor, but the goal of this grant is to enable the junior investigator to develop their own research program. It also must be clearly stated that the work submitted by the applicant is primarily that of the applicant, and any work or data from the senior mentor’s laboratory clearly defined.
• Resources allocated through this award are intended to support the career development of the applicant. Accordingly, requests for salary, fringe benefits or other support for the mentor are not allowed. Indirect costs are not allowed. Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Evidence for developing independence in research initiatives should be provided.
• Candidates are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. A sponsor is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
• Annually, a one-page plain language progress report, a scientific progress report, a financial statement, a list of publications based on the research and a letter of certification from the division chief or department chair, must be submitted by the award recipient by Nov. 30. Second year funding is contingent upon submission of this documentation. All publications, presentations and abstracts arising from work funded by this program must acknowledge support of the AGA-Aptalis Research Award in Pancreatic Disease.
There must be a strong commitment from the candidate’s institution to support the required protected time for research and adequate laboratory space and/or other supporting facilities. These commitments must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify that the award is being used to provide protected time, in accord with the terms of the award. In addition, it is expected that the sponsor will outline specific plans for the future development of the candidate’s research career. The institution must commit to ensuring timely and accurate reporting of the awardee’s current and future research activities at the institution; this is to include an annual report of the funding status, grants submitted and pending, and all publications.
The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission and evidence of institutional commitment. The candidate should state clearly how the additional training will benefit his/her research career.
A selection committee comprised of members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence October 2014.
The application deadline is June 6, 2014. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please email the application document to email@example.com. Direct all questions to the research awards manager via telephone at 301-222-4012 or email at firstname.lastname@example.org.
Funding for this award is provided by Aptalis Pharma US, Inc.
Lung Cancer Research Foundation Grant Program
Deadline: Friday, June 16, 2014
The Lung Cancer Research Foundation's grant program provides critical seed support for cutting-edge scientific research on all cancers of the lung. We believe this type of support can build proof of concept for researchers to apply for additional grant funding from universities and public sources.
LCRF GRANTS ARE AWARDED FOR LUNG CANCER PROJECTS FOCUSED ON:
• Basic Science
• Translational Research
• Clinical Research
• Supportive Care
• Quality of Care/Outcomes
LCRF PROVIDES FUNDS TO U.S. AND INTERNATIONAL INVESTIGATORS FROM NOT FOR PROFIT INSTITUTIONS:
• Graduate students
• Post-doctoral researchers
• Medical students
• Nurse researchers
Call for Applications: Sontag Foundation Distinguished Scientist Awards
Inspire us. We're looking for early career scientists with the potential to create new waves across the brain cancer field. We're looking for increased survival rates and improved recovery for patients. We're looking for a cure or at the very least, treatments to make brain cancer a manageable chronic disease.
Next Application deadline is March 20, 2014.
Eligibility Requirements for 2014 Distinguished Scientist Awards
Applicants must hold a doctoral degree in a discipline which can be brought to bear on the intractable disease, brain cancer.
At the time of application, applicants must hold their first independent full-time faculty appointment at the level of assistant professor, independent researcher or equivalent position at a tax-exempt 501(c)(3) academic, research or medical institution within the United States or an equivalent institution in Canada. If the institution grants tenure, the qualifying appointment must be on the tenure track.
Applicant's initial faculty appointment must have been made no earlier than March 1, 2011.
Applicant's career track and proposed research should demonstrate potential to generate new knowledge relating to causes, cure or treatment of primary brain tumors/brain cancer.
Research proposal submitted for funding must be a primary focus of applicant.
More than one individual from the same institution may apply for this award.
Reapplications in subsequent years of eligibility will be accepted by invitation only.
Up to $150,000 each of four years–as supported by budget request.